HP1370
LD 1852
PUBLIC Law, Chapter 578

Signed on 2012-04-02 00:00:00.0 - Second Regular Session - 125th Maine Legislature
 
 
Bill Tracking, Additional Documents Chamber Status

An Act To Provide a More Comprehensive Ban on the Possession of Synthetic Hallucinogenic Drugs

Be it enacted by the People of the State of Maine as follows:

Sec. 1. 17-A MRSA §1101, sub-§16-A, ¶¶G and H,  as enacted by PL 2011, c. 465, §5, are amended to read:

G. Napthylpyrovalerone, NRG-1; or
H. Beta-keto-N-methylbenzodioxolylpropylamine . ;

Sec. 2. 17-A MRSA §1101, sub-§16-A, ¶¶ I to O  are enacted to read:

I 4 - methylethcathinone, 4-MEC;
J Butylone;
K Eutylone;
L Pentedrone;
M Pentylone;
N 2, 5 - dimethoxy-4-ethylphenethylamine; or
O A derivative of cathinone, including any compound, material, mixture, preparation or other product, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl or thiophene ring systems, whether or not the compound is further modified in any of the following ways:

(1) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl or halide substituents, whether or not further substituted in the ring system by one or more other univalent substitutents;

(2) By substitution at the 3-position with an acyclic alkyl substituent; or

(3) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl or methoxybenzyl groups or by inclusion of the 2-amino nitrogen atom in a cyclic structure.

This paragraph does not include a drug listed in section 1102 or a drug approved by the United States Food and Drug Administration.

Effective 90 days following adjournment of the 125th Legislature, Second Regular Session, unless otherwise indicated.


Top of Page